1. An 80-gene set to predict response to preoperative chemoradiotherapy for rectal cancer by principle component analysis
   SHINICHIRO EMPUKU et al, 2016, Molecular and Clinical Oncology CrossRef
2. Preoperative chemoradiotherapy using S-1 combined with celecoxib for advanced lower rectal cancer: Phase I/II study
   Gaku Ohira et al, 2019, Journal of the Anus, Rectum and Colon CrossRef
3. Short‑term outcomes of preoperative chemoradiotherapy with S‑1 for locally advanced rectal cancer
   Masatsugu Hiraki et al, 2020, Molecular and Clinical Oncology CrossRef
4. Effect of S‐1 on blood levels of phenobarbital and phenytoin: A case report
   Ken Shiraiwa et al, 2021, Clinical Case Reports CrossRef
5. Tolerability and safety of adjuvant chemoradiotherapy with S-1 after limited surgery for T1 or T2 lower rectal cancer
   Mitsuyoshi Tei et al, 2021, International Journal of Clinical Oncology CrossRef
6. A multicenter phase II trial of preoperative chemoradiotherapy with S-1 plus oxaliplatin and bevacizumab for locally advanced rectal cancer
   Jun Higashijima et al, 2021, International Journal of Clinical Oncology CrossRef
7. Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancer
   Nobuki Imano et al, 2021, Journal of Radiation Research CrossRef
8. Long-term outcomes of neoadjuvant-synchronous S-1 plus radiotherapy for locally advanced rectal cancer: a multi-institutional prospective phase II study
   Takahiro Hiratsuka et al, 2018, Journal of the Anus, Rectum and Colon CrossRef
9. p62 is a useful predictive marker for tumour regression after chemoradiation therapy in patients with advanced rectal cancer: an immunohistochemical study
   Toshinori Kobayashi et al, 2021, Colorectal Disease CrossRef